Effect of hyperbaric oxygen in hepatopulmonary syndrome: an innovative experimental study

CONCLUSIONS: HBOT may be a promising treatment for HPS by reducing NO and NOS activity, perialveolar arteriolar dilation, lung inflammation, and injury and guiding future clinical trials.PMID:38567592 | DOI:10.26355/eurrev_202403_35733

Source: European Review for Medical and Pharmacological Sciences - April 3, 2024 Category: Drugs & Pharmacology Authors: M Altinkaynak G Simsek Y Unlu A Arslan S S Erdem A Kartal M A Eryilmaz Source Type: research